Risk stratification of pulmonary toxicities in the combination of whole lung irradiation and high-dose chemotherapy for Ewing sarcoma patients with lung metastases: a review Sergiu ScobioalaHans Theodor Eich Review Article Open access 12 March 2020 Pages: 495 - 504
Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters Ying ZhouTiansheng YanYouling Gong Original Article 11 December 2019 Pages: 505 - 514
Age-dependent hemato- and nephrotoxicity in patients with head and neck cancer receiving chemoradiotherapy with weekly cisplatin Fabian WeykampKatharina SeidensaalStefan Ezechiel Welte Original Article 29 November 2019 Pages: 515 - 521
Influence of radiation dose to pharyngeal constrictor muscles on late dysphagia and quality of life in patients with locally advanced oropharyngeal carcinoma S. MogadasC.-J. BuschS. Tribius Original Article 31 January 2020 Pages: 522 - 529
Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study Wen-jun FanFeng TengLin Ma Original Article Open access 05 February 2020 Pages: 530 - 541
PET/MRI and genetic intrapatient heterogeneity in head and neck cancers Kerstin ClasenSara LeibfarthDaniela Thorwarth Original Article 24 March 2020 Pages: 542 - 551
Prognostic value of a 15-gene hypoxia classifier in oropharyngeal cancer treated with accelerated chemoradiotherapy Sarah DeschuymerBrita Singers SørensenSandra Nuyts Original Article 20 February 2020 Pages: 552 - 560
Model-based calculation of thyroid gland normal tissue complication probability in head and neck cancer patients after radiation therapy Ivana KinclováEva HajtmanováKatarína Kozlíková Original Article 03 February 2020 Pages: 561 - 568
Radiotherapy for osteoarthritis of the ankle and tarsal joints—analysis of 66 joints Matthias G. HautmannMatthias HippChristoph Süß Original Article 29 November 2019 Pages: 569 - 575
Organerhaltende Therapie des Harnblasenkarzinoms Jürgen Dunst Literatur kommentiert Open access 27 April 2020 Pages: 576 - 578
Verminderung des Risikos eines In-Brust-Rezidivs: externe akzelerierte Teilbrust- vs. Ganzbrustradiotherapie für brusterhaltend operierte Patientinnen mit DCIS oder nodal-negativem Mammakarzinom Rainer Souchon Literatur kommentiert 27 April 2020 Pages: 579 - 582
Dosimetrie für „tumor treating fields“ – applizierte Energie korreliert mit onkologischen Ergebnissen bei Glioblastompatienten in der Studie EF-14 Robert Michael HermannRoland Merten Literatur kommentiert 01 April 2020 Pages: 583 - 585